HPR168 Lessons Learned From NOACs and CV Drugs That Have Launched in the EU5, US, JP and BR? An HTA Review and Evidence Generation Standpoint
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1297
https://www.valueinhealthjournal.com/article/S1098-3015(22)03502-1/fulltext
Title :
HPR168 Lessons Learned From NOACs and CV Drugs That Have Launched in the EU5, US, JP and BR? An HTA Review and Evidence Generation Standpoint
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03502-1&doi=10.1016/j.jval.2022.09.1297
First page :
Section Title :
Open access? :
No
Section Order :
10848